Projects funded by the NCN
Anilide derivatives of long-chain cyclic amines as multifunctional serotonin receptors ligands and phosphodiesterase 7 inhibitors with potential use in the treatment of cognitive and depressive disorders in Alzheimer's disease
2017/25/N/NZ7/00544
Keywords:
Alzheimer's disease cognitive disorders depressive disorders procognitive activity antidepressant activity multifunctional ligands 5-HT1A receptor ligands 5-HT7 receptor ligands PDE7 inhibitors
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 13 - announced on 2017-03-15
Amount awarded: 179 992 PLN
Project start date (Y-m-d): 2018-02-01
Project end date (Y-m-d): 2022-01-31
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.